PubMed:8392092
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-142 | Sentence | denotes | Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. |
| T2 | 143-439 | Sentence | denotes | We have previously shown that minimally oxidized LDL (MM-LDL) activated endothelial cells to increase their interaction with monocytes but not neutrophils, inducing monocyte but not neutrophil binding and synthesis of monocyte chemotactic protein-1 and monocyte colony-stimulating factor (M-CSF). |
| T3 | 440-555 | Sentence | denotes | In the present studies we have examined the signaling pathways by which this monocyte-specific response is induced. |
| T4 | 556-693 | Sentence | denotes | Both induction of monocyte binding and mRNA levels for M-CSF by MM-LDL were not inhibited in protein kinase C-depleted endothelial cells. |
| T5 | 694-799 | Sentence | denotes | A number of our studies indicate that cAMP is the second messenger for the effects of MM-LDL cited above. |
| T6 | 800-896 | Sentence | denotes | Incubation of endothelial cells with MM-LDL caused a 173% increase in intracellular cAMP levels. |
| T7 | 897-1040 | Sentence | denotes | Agents which increased cAMP levels, including cholera toxin, pertussis toxin, dibutyryl cAMP, and isoproterenol mimicked the actions of MM-LDL. |
| T8 | 1041-1207 | Sentence | denotes | Agents which elevated cAMP were also shown to activate NF kappa B, suggesting a role for this transcription factor in activation of monocyte-endothelial interactions. |
| T9 | 1208-1397 | Sentence | denotes | Although endothelial leukocyte adhesion molecule (ELAM) mRNA synthesis can be regulated by NF kappa B, ELAM was not expressed and ELAM mRNA was only slightly elevated in response to MM-LDL. |
| T10 | 1398-1521 | Sentence | denotes | We present evidence that induction of neutrophil binding by LPS is actually suppressed by agents that elevated cAMP levels. |
| T1 | 0-142 | Sentence | denotes | Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. |
| T2 | 143-439 | Sentence | denotes | We have previously shown that minimally oxidized LDL (MM-LDL) activated endothelial cells to increase their interaction with monocytes but not neutrophils, inducing monocyte but not neutrophil binding and synthesis of monocyte chemotactic protein-1 and monocyte colony-stimulating factor (M-CSF). |
| T3 | 440-555 | Sentence | denotes | In the present studies we have examined the signaling pathways by which this monocyte-specific response is induced. |
| T4 | 556-693 | Sentence | denotes | Both induction of monocyte binding and mRNA levels for M-CSF by MM-LDL were not inhibited in protein kinase C-depleted endothelial cells. |
| T5 | 694-799 | Sentence | denotes | A number of our studies indicate that cAMP is the second messenger for the effects of MM-LDL cited above. |
| T6 | 800-896 | Sentence | denotes | Incubation of endothelial cells with MM-LDL caused a 173% increase in intracellular cAMP levels. |
| T7 | 897-1040 | Sentence | denotes | Agents which increased cAMP levels, including cholera toxin, pertussis toxin, dibutyryl cAMP, and isoproterenol mimicked the actions of MM-LDL. |
| T8 | 1041-1207 | Sentence | denotes | Agents which elevated cAMP were also shown to activate NF kappa B, suggesting a role for this transcription factor in activation of monocyte-endothelial interactions. |
| T9 | 1208-1397 | Sentence | denotes | Although endothelial leukocyte adhesion molecule (ELAM) mRNA synthesis can be regulated by NF kappa B, ELAM was not expressed and ELAM mRNA was only slightly elevated in response to MM-LDL. |
| T10 | 1398-1521 | Sentence | denotes | We present evidence that induction of neutrophil binding by LPS is actually suppressed by agents that elevated cAMP levels. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 31-42 | protein | denotes | lipoprotein |
| T2 | 77-94 | cell_type | denotes | endothelial cells |
| T3 | 173-232 | cell_line | denotes | minimally oxidized LDL (MM-LDL) activated endothelial cells |
| T4 | 268-277 | cell_type | denotes | monocytes |
| T5 | 286-297 | cell_type | denotes | neutrophils |
| T6 | 361-391 | protein | denotes | monocyte chemotactic protein-1 |
| T7 | 396-430 | protein | denotes | monocyte colony-stimulating factor |
| T8 | 432-437 | protein | denotes | M-CSF |
| T9 | 611-616 | protein | denotes | M-CSF |
| T10 | 620-626 | protein | denotes | MM-LDL |
| T11 | 675-692 | cell_type | denotes | endothelial cells |
| T12 | 780-786 | protein | denotes | MM-LDL |
| T13 | 814-831 | cell_type | denotes | endothelial cells |
| T14 | 837-843 | protein | denotes | MM-LDL |
| T15 | 1033-1039 | protein | denotes | MM-LDL |
| T16 | 1096-1106 | protein | denotes | NF kappa B |
| T17 | 1217-1268 | RNA | denotes | endothelial leukocyte adhesion molecule (ELAM) mRNA |
| T18 | 1299-1309 | protein | denotes | NF kappa B |
| T19 | 1311-1315 | protein | denotes | ELAM |
| T20 | 1338-1347 | RNA | denotes | ELAM mRNA |
| T21 | 1390-1396 | protein | denotes | MM-LDL |
| T22 | 1436-1446 | cell_type | denotes | neutrophil |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-142 | Sentence | denotes | Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. |
| S2 | 143-439 | Sentence | denotes | We have previously shown that minimally oxidized LDL (MM-LDL) activated endothelial cells to increase their interaction with monocytes but not neutrophils, inducing monocyte but not neutrophil binding and synthesis of monocyte chemotactic protein-1 and monocyte colony-stimulating factor (M-CSF). |
| S3 | 440-555 | Sentence | denotes | In the present studies we have examined the signaling pathways by which this monocyte-specific response is induced. |
| S4 | 556-693 | Sentence | denotes | Both induction of monocyte binding and mRNA levels for M-CSF by MM-LDL were not inhibited in protein kinase C-depleted endothelial cells. |
| S5 | 694-799 | Sentence | denotes | A number of our studies indicate that cAMP is the second messenger for the effects of MM-LDL cited above. |
| S6 | 800-896 | Sentence | denotes | Incubation of endothelial cells with MM-LDL caused a 173% increase in intracellular cAMP levels. |
| S7 | 897-1040 | Sentence | denotes | Agents which increased cAMP levels, including cholera toxin, pertussis toxin, dibutyryl cAMP, and isoproterenol mimicked the actions of MM-LDL. |
| S8 | 1041-1207 | Sentence | denotes | Agents which elevated cAMP were also shown to activate NF kappa B, suggesting a role for this transcription factor in activation of monocyte-endothelial interactions. |
| S9 | 1208-1397 | Sentence | denotes | Although endothelial leukocyte adhesion molecule (ELAM) mRNA synthesis can be regulated by NF kappa B, ELAM was not expressed and ELAM mRNA was only slightly elevated in response to MM-LDL. |
| S10 | 1398-1521 | Sentence | denotes | We present evidence that induction of neutrophil binding by LPS is actually suppressed by agents that elevated cAMP levels. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 173-232 | NP | denotes | minimally oxidized LDL (MM-LDL) activated endothelial cells |
| C2 | 245-250 | NP | denotes | their |
| C3 | 480-502 | NP | denotes | the signaling pathways |
| C4 | 506-511 | NP | denotes | which |
| C5 | 620-626 | NP | denotes | MM-LDL |
| C6 | 732-736 | NP | denotes | cAMP |
| C7 | 740-798 | NP | denotes | the second messenger for the effects of MM-LDL cited above |
| C8 | 837-843 | NP | denotes | MM-LDL |
| C9 | 897-903 | NP | denotes | Agents |
| C10 | 904-909 | NP | denotes | which |
| C11 | 920-924 | NP | denotes | cAMP |
| C12 | 1033-1039 | NP | denotes | MM-LDL |
| C14 | 1041-1047 | NP | denotes | Agents |
| C15 | 1048-1053 | NP | denotes | which |
| C16 | 1063-1067 | NP | denotes | cAMP |
| C13 | 1041-1067 | NP | denotes | Agents which elevated cAMP |
| C17 | 1096-1106 | NP | denotes | NF kappa B |
| C18 | 1130-1155 | NP | denotes | this transcription factor |
| C19 | 1217-1268 | NP | denotes | endothelial leukocyte adhesion molecule (ELAM) mRNA |
| C20 | 1299-1309 | NP | denotes | NF kappa B |
| C21 | 1338-1347 | NP | denotes | ELAM mRNA |
| C22 | 1390-1396 | NP | denotes | MM-LDL |
| C23 | 1488-1520 | NP | denotes | agents that elevated cAMP levels |
| R1 | C2 | C1 | coref-pron | their,minimally oxidized LDL (MM-LDL) activated endothelial cells |
| R2 | C4 | C3 | coref-relat | which,the signaling pathways |
| R3 | C7 | C6 | coref-ident | the second messenger for the effects of MM-LDL cited above,cAMP |
| R4 | C8 | C5 | coref-ident | MM-LDL,MM-LDL |
| R5 | C10 | C9 | coref-relat | which,Agents |
| R6 | C11 | C6 | coref-ident | cAMP,cAMP |
| R7 | C12 | C8 | coref-ident | MM-LDL,MM-LDL |
| R8 | C15 | C13 | coref-relat | which,Agents which elevated cAMP |
| R9 | C16 | C11 | coref-ident | cAMP,cAMP |
| R10 | C18 | C17 | coref-ident | this transcription factor,NF kappa B |
| R11 | C20 | C17 | coref-ident | NF kappa B,NF kappa B |
| R12 | C21 | C19 | coref-ident | ELAM mRNA,endothelial leukocyte adhesion molecule (ELAM) mRNA |
| R13 | C22 | C12 | coref-ident | MM-LDL,MM-LDL |
| R14 | C23 | C14 | coref-ident | agents that elevated cAMP levels,Agents |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-30 | other_name | denotes | low density |
| T2 | 31-42 | protein_domain_or_region | denotes | lipoprotein |
| T3 | 77-94 | cell_type | denotes | endothelial cells |
| T4 | 111-141 | nucleotide | denotes | cyclic adenosine monophosphate |
| T5 | 173-197 | cell_line | denotes | minimally oxidized LDL ( |
| T6 | 197-203 | protein_family_or_group | denotes | MM-LDL |
| T7 | 215-232 | cell_type | denotes | endothelial cells |
| T8 | 268-277 | cell_type | denotes | monocytes |
| T9 | 286-297 | cell_type | denotes | neutrophils |
| T10 | 308-316 | other_name | denotes | monocyte |
| T11 | 325-343 | other_name | denotes | neutrophil binding |
| T12 | 361-391 | protein_molecule | denotes | monocyte chemotactic protein-1 |
| T13 | 396-430 | protein_molecule | denotes | monocyte colony-stimulating factor |
| T14 | 432-437 | protein_molecule | denotes | M-CSF |
| T15 | 517-543 | other_name | denotes | monocyte-specific response |
| T16 | 574-590 | other_name | denotes | monocyte binding |
| T17 | 595-606 | other_name | denotes | mRNA levels |
| T18 | 611-616 | protein_molecule | denotes | M-CSF |
| T19 | 620-626 | protein_family_or_group | denotes | MM-LDL |
| T20 | 675-692 | cell_type | denotes | endothelial cells |
| T21 | 732-736 | nucleotide | denotes | cAMP |
| T22 | 780-786 | protein_family_or_group | denotes | MM-LDL |
| T23 | 814-831 | cell_type | denotes | endothelial cells |
| T24 | 837-843 | protein_family_or_group | denotes | MM-LDL |
| T25 | 884-888 | nucleotide | denotes | cAMP |
| T26 | 920-924 | nucleotide | denotes | cAMP |
| T27 | 943-956 | other_organic_compound | denotes | cholera toxin |
| T28 | 958-973 | other_organic_compound | denotes | pertussis toxin |
| T29 | 975-989 | amino_acid_monomer | denotes | dibutyryl cAMP |
| T30 | 995-1008 | other_organic_compound | denotes | isoproterenol |
| T31 | 1033-1039 | protein_family_or_group | denotes | MM-LDL |
| T32 | 1063-1067 | nucleotide | denotes | cAMP |
| T33 | 1096-1106 | protein_molecule | denotes | NF kappa B |
| T34 | 1217-1256 | protein_molecule | denotes | endothelial leukocyte adhesion molecule |
| T35 | 1258-1262 | protein_molecule | denotes | ELAM |
| T36 | 1299-1309 | protein_molecule | denotes | NF kappa B |
| T37 | 1311-1315 | protein_molecule | denotes | ELAM |
| T38 | 1338-1342 | protein_molecule | denotes | ELAM |
| T39 | 1390-1396 | protein_family_or_group | denotes | MM-LDL |
| T40 | 1436-1446 | cell_type | denotes | neutrophil |
| T41 | 1458-1461 | lipid | denotes | LPS |
| T42 | 1509-1513 | nucleotide | denotes | cAMP |